Among these, VIPR1 has been identified as a protective gene for the survival of NSCLC patients, whereas NEK2, HMGA1, FERMT1, SLC7A5, and TNS4 are risk genes. This evidence concerns the gene VIPR1 and non-small cell lung carcinoma.